CSIMarket Company Name, Ticker, Competitors, else..
 
Indivior Pharmaceuticals Inc   (NASDAQ: INDV)
 
Price: $34.8300 $-0.22 -0.628%
Day's High: $35.22999954223633 Week Perf: -0.11 %
Day's Low: $ 34.57 30 Day Perf: -10.07 %
Volume (M): 1,547,614 52 Wk High: $ 44.00
Volume (M$): $ 0 52 Wk Avg: $33.52
Open: $35.18 52 Wk Low: $22.22



 Market Capitalization (Millions $) 4,493
 Shares Outstanding (Millions) 129
 Employees 1,000
 Revenues (TTM) (Millions $) 1,292
 Net Income (TTM) (Millions $) 252
 Cash Flow (TTM) (Millions $) -197
 Capital Exp. (TTM) (Millions $) 82

Business Description


The company operates in the pharmaceutical and biotechnology industries, specializing in the development, marketing, and sales of pharmaceutical products. It competes in areas such as product development, sales force expansion, and regulatory compliance. The company is subject to U.S. and international laws related to healthcare fraud, abuse, and transparency, including the Anti-Kickback Statute, False Claims Act, HIPAA, and various state laws. It depends on key personnel to manage its operations and ensure adherence to these complex legal requirements.


   Company Address: 10710 Midlothian Turnpike, Suite 125 North Chesterfield 23235 VA
   Company Phone Number: 379-1090   Stock Exchange / Ticker: NASDAQ INDV


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AKBA        4.61% 
ALKS   -4.13%    
AMRX   -0.78%    
ASRT      0% 
BHC        7.3% 
MNK   -39.2%    
• View Complete Report
   



Announcement

Indivior PLC Investors Advised to Act Ahead of Class Action Deadline

Published Thu, Sep 5 2024 5:26 PM UTC

: This article addresses the ongoing securities class action involving Indivior PLC, providing important information regarding the associated deadlines for affected investors. Rosen Law Firm, a notable global entity focused on investor rights, has issued reminders to potential plaintiffs regarding their rights and the necessary steps to secure legal representation in light ...
Stocks on the Move

Indivior Plc Faces Challenges and Investor Uncertainty Amidst Market Turmoil

Published Tue, Jul 16 2024 9:56 AM UTC

Indivior Plc, a leading pharmaceutical company specializing in addiction treatment drugs, has recently faced a series of setbacks, sending shockwaves throughout the industry and causing investor concern. With a sharp drop in share prices, profit warnings, discontinued drug sales, job cuts, and ongoing investigations, Indivior s future hangs in the balance. This article delve...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 17.77
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 3.48
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.21
Working Capital Ratio 0.69
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.84

Per Share Current
Earnings (TTM) 1.96 $
Revenues (TTM) 10.02 $
Cash Flow (TTM) -
Cash 1.36 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 1,292,000
Net Income per Employee (TTM) 252,000
Receivable Turnover Ratio (TTM) 5.04
Inventory Turnover Ratio (TTM) 3.03
Asset Turnover Ratio (TTM) 0.98

Profitability Ratios Current
Gross Margin (MRQ) 87.38 %
Operating Margin (MRQ) 43.22 %
Net Margin (MRQ) 28.08 %
Net Cash Flow Margin (MRQ) -6.31 %
Effective Tax Rate (TTM) 15.25 %

Management Effectiveness Current
Return On Assets (TTM) 19.14 %
Return On Investment (TTM) 37.77 %
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Indivior Pharmaceuticals Inc's Segments
Reportable Segment    100 % of total Revenue
Reportable SUBLOCADE    73.19 % of total Revenue
Reportable US    85.8 % of total Revenue
Reportable US SUBLOCADE    68.77 % of total Revenue
Reportable US Sublingual other    15.77 % of total Revenue
Reportable US PERSERIS    1.58 % of total Revenue
Reportable Rest of World    14.2 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.